MDCX 424B3: Stock split
Medicus Pharma Ltd.
Filed with the SEC on · accession 0001062993-26-005229
MDCX filed a 424B3 (prospectus (offering)) with the SEC on Oct 7, 2026. Medicus Pharma Ltd. announced a 50-to-1 reverse stock split (share consolidation) effective October 12, 2026, intended to increase the bid price of its common shares and regain compliance with Nasdaq's minimum bid price requirement. The stock moved +0.6% by the first close after the filing.
Summary of the filing
Medicus Pharma Ltd. announced a 50-to-1 reverse stock split (share consolidation) effective October 12, 2026, intended to increase the bid price of its common shares and regain compliance with Nasdaq's minimum bid price requirement. Every 50 common shares will be exchanged for one new common share, with no fractional shares issued.
Key details
How MDCX stock reacted
Close before
$7.96
Oct 6, 2026
First close after
+0.63%
$8.01
5 trading days
-58.79%
$3.28
Since filing
-76.51%
$1.87
✦ Ask GOAX AI about this filing — what it means for MDCX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MDCX?
Click hereFrequently asked questions
What did MDCX file with the SEC on Oct 7, 2026?
MDCX filed a 424B3 (Stock split). Medicus Pharma Ltd. announced a 50-to-1 reverse stock split (share consolidation) effective October 12, 2026, intended to increase the bid price of its common shares and regain compliance with Nasdaq's minimum bid price requirement. Every 50 common shares will be exchanged for one new common share, with no fractional shares issued.
What does a stock split mean for MDCX stock?
Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did MDCX stock react to this filing?
MDCX closed at $7.96 before the filing and $8.01 on Oct 7, 2026 (+0.63%). Five trading days later: $3.28 (-58.79%).
Other MDCX SEC filings
- 10-Q · SEC filingNov 6, 2026
- 424B3 · Shelf registrationNov 6, 2026
- 8-K · AcquisitionNov 4, 2026
- DEF 14A · Stock splitOct 30, 2026
- 424B3 · Delisting noticeOct 26, 2026
- 8-K · Delisting noticeOct 23, 2026
- SCHEDULE 13G/A · SEC filingOct 16, 2026
- 424B3 · Stock splitOct 16, 2026
- 8-K · Stock splitOct 7, 2026
- 8-K · Material agreementSep 14, 2026
Get alerts when MDCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days